Regeneron Pharmaceuticals
REGN
#393
Rank
NZ$110.67 B
Marketcap
NZ$1,056
Share price
0.46%
Change (1 day)
22.36%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2026 (TTM): NZ$8.78 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are NZ$14.91 Billion. In 2025 the company made an earning of NZ$8.97 Billion, an increase over its 2024 earnings that were of NZ$8.20 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$8.78 B-2.2%
2025 NZ$8.97 B9.43%
2024 NZ$8.20 B13.83%
2023 NZ$7.20 B-13.57%
2022 NZ$8.34 B-47.9%
2021 NZ$16.00 B144.75%
2020 NZ$6.54 B56.86%
2019 NZ$4.16 B-4.87%
2018 NZ$4.38 B22.86%
2017 NZ$3.56 B56.3%
2016 NZ$2.28 B8.55%
2015 NZ$2.10 B54.53%
2014 NZ$1.36 B11.14%
2013 NZ$1.22 B72.13%
2012 NZ$0.71 B-285.93%
2011 -NZ$0.39 Billion121.73%
2010 -NZ$0.18 Billion37.18%
2009 -NZ$0.13 Billion-14.6%
2008 -NZ$0.15 Billion-25.02%
2007 -NZ$0.2 Billion6.32%
2006 -NZ$0.19 Billion-186.52%
2005 NZ$0.21 B2103.7%
2004 NZ$9.69 M-105.66%
2003 -NZ$0.18 Billion-18.18%
2002 -NZ$0.21 Billion42.33%
2001 -NZ$0.15 Billion129.35%
2000 -NZ$64.14 Million51.87%
1999 -NZ$42.23 Million92.19%
1998 -NZ$21.98 Million66.23%
1997 -NZ$13.22 Million-55.49%
1996 -NZ$29.7 Million103.53%
1995 -NZ$14.6 Million-70.89%
1994 -NZ$50.13 Million-26.08%
1993 -NZ$67.81 Million114.67%
1992 -NZ$31.59 Million196.77%
1991 -NZ$10.65 Million87.88%
1990 -NZ$5.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.59 B 403.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.09 B 206.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
NZ$15.59 B 76.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$13.14 B 48.51%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$2.78 B-68.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$1.49 B-83.14%๐Ÿ‡บ๐Ÿ‡ธ USA